Protalix BioTherapeutics to Participate in Upcoming Investor Conferences in January
- Monday, January 4, 2021, 7:02
- Finance
- Add a comment
CARMIEL, Israel, Jan. 4, 2021 /PRNewswire/ — Protalix BioTherapeutics, Inc. (NYSE American: PLX) (TASE: PLX), a biopharmaceutical company focused on the development, production and commercialization of recombinant therapeutic proteins produced by its proprietary ProCellEx® plant…
About the Author
adminasapcorp has written 41546 stories on this site.